CEL-SCI Corporation

Last-ditch attempts by CEL-SCI to persuade investors that its cancer drug candidate Multikine has a future have fallen flat and the company may be facing bankruptcy and the end of its chequered hist

Below is Scrip’s regular roundup, including information from Strategic Transactions , of recent technology transfer agreements and collaborations between companies and academic or other research inst

Cel-Sci Corp. and Ergomed PLC have voiced relief at the FDA's decision to remove the clinical hold placed on a Phase III study evaluating Multikine (Leukocyte Interleukin, Injection) in head a

IN VITRO DIAGNOSTICS ALLIANCES Akers Biosciences Inc. Alere Inc. First Check Diagnostics LLC Akers Biosciences Inc. licensed Alere Inc. 's First Check Diagnostics LLC exclusive US distribut